1.28 USD
↗ 0.16 (14.29%)PRE MARKET (AS OF 04:06 AM EDT)
RenovoRx, Inc. Common Stock
RNXTNASDAQ • USD
Market: OPEN
RenovoRx, Inc. Common Stock (RNXT) is currently trading at $1.28. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 13, 2026.
Open?$1.22
High?$1.28
Low?$1.22
Prev. Close?$1.12
Volume?259
Avg. Volume?292.8K
VWAP?$1.26
Rel. Volume?0.00x
Bid / Ask
Bid?$1.06 × 100
Ask?$1.45 × 100
Spread?$0.39
Midpoint?$1.26
Valuation & Ratios
Market Cap?56.8M
Shares Out?45.1M
Float?43.4M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?5.04
EPS?-$0.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Employees
17
Market Cap
50.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-26
Address
2570 W. EL CAMINO REAL, STE. 320,
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
MOUNTAIN VIEW, CA 94040
Phone: 408-800-2649
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?94
Momentum?65
Short Sent.?95
Piotroski F-Score?2/9Weak
Altman Z-Score?4.20Safe
Confidence?46%Low
Short InterestLow
Short % of Float?0.65%Low
Short Interest?283.4K
Days to Cover?1.4
Free Float43.4M
Avg Daily Volume197.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?7.15Strong
Quick Ratio?6.95Strong
Cash Ratio?6.44Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.04FAIR▾
Peers100
S&P37
P/S?38.16HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.5CHEAP▾
S&P97
EV/Sales?29.86HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-108.9%WEAK▾
S&P3
ROA?-87.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11301000
Enterprise Value?$44.5M
Fundamentals ratios updated end of day